share_log

Allarity Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Epshinsky Alexander

SEC ·  Sep 18, 2024 16:08

Summary by Moomoo AI

Alexander Epshinsky, the Chief Financial Officer of Allarity Therapeutics, Inc. (ALLR), has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 document dated 09/12/2024. The filing indicates that Epshinsky beneficially owns 55,555 common stock shares, which were granted as employment inducement awards in line with his appointment as CFO. These restricted stock units (RSUs) are set to vest in equal installments over three years, contingent upon his continued employment with the company. The inducement grant complies with Nasdaq listing rule 5635(c)(4), and the filing was completed on 09/18/2024.
Alexander Epshinsky, the Chief Financial Officer of Allarity Therapeutics, Inc. (ALLR), has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 document dated 09/12/2024. The filing indicates that Epshinsky beneficially owns 55,555 common stock shares, which were granted as employment inducement awards in line with his appointment as CFO. These restricted stock units (RSUs) are set to vest in equal installments over three years, contingent upon his continued employment with the company. The inducement grant complies with Nasdaq listing rule 5635(c)(4), and the filing was completed on 09/18/2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    SciSparc
    SPRC
    -- 1.0700
    Unity Biotechnology
    UBX
    -- 1.7800
    BioXcel Therapeutics
    BTAI
    -- 0.573
    Sagimet Biosciences
    SGMT
    -- 6.780
    Vor Biopharma
    VOR
    -- 1.740

    Unlock the Full List